Page last updated: 2024-10-28
phenelzine and ER-Negative PR-Negative HER2-Negative Breast Cancer
phenelzine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Tan, AHY | 1 |
| Tu, W | 1 |
| McCuaig, R | 1 |
| Hardy, K | 1 |
| Donovan, T | 1 |
| Tsimbalyuk, S | 1 |
| Forwood, JK | 1 |
| Rao, S | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| A Phase Ib Safety and Pharmacokinetics (PK)/ Pharmacodynamics (PD) Study to Determine the Dosage of Abraxane in Combination With Phenelzine Sulfate in Metastatic or Inoperable Locally Advanced Breast Cancer[NCT03505528] | Phase 1 | 8 participants (Actual) | Interventional | 2017-08-17 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for phenelzine and ER-Negative PR-Negative HER2-Negative Breast Cancer